Autoimmune Diseases and the Importance of Their Treatment in the Modern Society

0 Comment

The research should be considered as the basis (from a theory and practice perspective) of immunology as it is known today. During the years that followed the above studies, immunology was developed furthermore and many theories were stated while the methods of treatment were differentiated in order to respond to the changing living standards and styles of life. The main reason for the choice of the particular topic has been its importance for patients that suffer from one of the types of the particular disease. In fact, a study published in the Environmental Health Perspective (2003, 483) proved that autoimmune diseases are chronic, potentially life-threatening conditions. there are more than 80 recognized autoimmune diseases including systemic lupus erythematosus, glomerulonephritis, multiple sclerosis, autoimmune thyroiditis, rheumatoid arthritis, and myositis. The diseases that belong in the specific category are quite common and appear in millions of people annually. As for the medical research made in the particular sector, this cannot be characterized as satisfactory regarding the treatment of the particular disease. However, the efforts for the thorough investigation of the issue are continuous. In this context, the current paper focuses on the presentation of the most recent developments related to the treatment of autoimmune diseases with a special reference to women.The treatment applied in each particular type of autoimmune disease presents significant differentiation in accordance with the conditions of each particular case, the symptoms presented and the patient’s personal medical history. Generally, it was supported by Blank et al. (2007, 1) that current pharmacological strategies for treating autoimmune diseases involve global use of broad-acting immunosuppressants that with long term use have associated toxicities. The present drive-in drug development is towards therapies that target a specific biological pathway or pathogenic cell population (Blank et al., 2007, 1).